Fingerprint
Dive into the research topics of 'Phase II study of sunitinib as second-line treatment for advanced gastric cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase II study of sunitinib as second-line treatment for advanced gastric cancer
Yung Jue Bang, Yoon Koo Kang, Won K. Kang, Narikazu Boku, Hyun C. Chung, Jen Shi Chen, Toshihiko Doi, Yan Sun, Lin Shen, Shukui Qin, Wai Tong Ng, Jennifer M. Tursi, Maria J. Lechuga, Dongrui Ray Lu, Ana Ruiz-Garcia, Alberto Sobrero
Research output: Contribution to journal › Article › peer-review
166
Citations
(Scopus)